Global Nebulizer Market Size study & Forecast, by Type (Jet, Mesh, Ultrasonic) by End-use (Hospitals & Clinics, Emergency Centers, Home Healthcare) and Regional Analysis, 2022-2029

Global Nebulizer Market Size study & Forecast, by Type (Jet, Mesh, Ultrasonic) by End-use (Hospitals & Clinics, Emergency Centers, Home Healthcare) and Regional Analysis, 2022-2029

Global Nebulizer Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Nebulizer is a medical device that converts the medicine into mist and delivers it directly to the lungs. These devices, generally consists of a motor, mouthpiece, cup, and tubing, use oxygen, compressed air, or ultrasonic power to break up the liquid drug into aerosols, turning it into a fine mist. These are prescribed by doctors to patients who suffer to take deep breaths when using an inhaler. Nebulizers are typically used to treat severe respiratory problems such cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, and others. The key factor driving the market growth is rising incidence of respiratory disease worldwide, increasing demand for innovative respiratory medicinal delivery devices and the growing geriatric population are likely to boost the market growth over the forecast period.

The rising prevalence of respiratory disorders such as Asthma, Chronic Obstructive Pulmonary Disorder (COPD), and other is anticipated to create the demand for Nebulizers for the treatment. According to the National Asthma Prevalence Report 2020 by the Centers for Disease Control and Prevention (CDC), there were 25,257,138 Americans that have asthma, of whom 4,226,659 were children under the age of 18 and 21,030,479 were adults over the age of 18. Due to this, it is predicted that the market would rise because of the rising incidence of asthma. Additionally, the development of technologically advanced nebulizers in various regions of the world is also accelerating the market's growth. For instance, in 2002, AireHealth garnered 510(k) clearance from the FDA for its connected nebulizer labelled as VitalMed. The device is a portable, electronic vibrating mesh nebulizer made for patients to inhale liquid medicines both inside and outside of the home. The market is growing as a result of these approvals. Also, growing demand for demand for home healthcare devices would create the lucrative opportunity for the market during forecast period. However, the drug loss during drug delivery may stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Nebulizer Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the rising respiratory disorders and efforts by the government such as favorable reimbursement policies, increase in customer awareness, and well established healthcare infrastructure in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising geriatric population, growing focus on preventive care, and govt. initiatives promoting technological innovations would create lucrative growth prospects for the Nebulizer market across Asia Pacific region.

Major market player included in this report are:
Omron Corporation
GE Healthcare
Koninklijke Philips N.V.
Allied Healthcare
Vectura Group Plc.
PARI Respiratory Equipment, Inc.
Aerogen
DeVilbiss Healthcare LLC
Briggs Healthcare
Beurer GmBH

Recent Developments in the Market:
 In 2021, PARI Pharma GmbH earned approval for the LAMIRA nebulizer system to deliver ARIKAYCE (amikacin liposome inhalation suspension) in Japan. The device has a customized drug reservoir with an 8.4 ml dose capacity and a specially designed aerosol head with a valved aerosol chamber for the aerosolization of ARIKAYCE.


Global Nebulizer Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, End-use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:

By Type:
Jet
Mesh
Ultrasonic
By End-use:
Hospitals & Clinics
Emergency Centers
Home Healthcare
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Omron Corporation
GE Healthcare
Koninklijke Philips N.V.
Allied Healthcare
Vectura Group Plc.
PARI Respiratory Equipment, Inc.
Aerogen
DeVilbiss Healthcare LLC
Briggs Healthcare
Beurer GmBH

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.